UK Parliament / Open data

Medicines and Medical Devices Bill

I thank the Minister for his extensive response. Essentially, he has relied on the well-known departmental argument that, by listing certain categories of organisation, you exclude others. However, legislation that has been passed in the last few years has often contained extensive lists of organisations to be consulted. Amendment 128, which I support, would give Ministers the power to consult any other persons that the authority considered appropriate. I wonder whether the Minister will just answer this. He would surely accept that this Bill is highly unusual in giving a huge amount of powers to Ministers essentially to change primary legislation through regulation and extensively to alter the regulatory framework for medicines and medical devices. Given that, we should be careful about similarly open-ended regulations on consultation. The amendment would provide reassurance to the key sectors that they will be

consulted, but it would also give discretionary power to Ministers to add to that on the occasions when greater flexibility was needed.

4.15 pm

About this proceeding contribution

Reference

807 cc646-7GC 

Session

2019-21

Chamber / Committee

House of Lords Grand Committee
Back to top